Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Moodys
Dow
Merck
McKinsey

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Patent: 5,230,997

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,230,997
Title: Methods of detecting the presence of human herpesvirus-7 infection
Abstract:The present invention relates to a new human herpesvirus-7, proteins encoded in the genome of the virus, and antibodies specific for the virus and proteins. The virus was isolated from human peripheral blood mononuclear cells following incubation of the cells under conditions promoting T cell activation. Cultures of lymphocytes infected with the virus exhibited a cytopathic effect and electron microscopic analyses revealed a characteristic herpesvirus structure. The new virus is distinct from previously characterized human herpesviruses. The invention also relates to bioassays for the diagnosis of human herpesvirus-7 and the detection of human herpesvirus-7 in a biological sample. It further relates to a vaccine for humans against human herpesvirus-7.
Inventor(s): Frenkel; Niza (Rockville, MD)
Assignee: The United States of America as represented by the Department of Health (Washington, DC)
Application Number:07/553,798
Patent Claims:see list of patent claims

Details for Patent 5,230,997

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Ag CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN immune globulin intravenous (human) For Injection 102367 2000-07-27 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2007-07-26 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2009-10-02 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2013-02-07 ⤷  Try it Free 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
McKesson
McKinsey
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.